v3.26.1
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)
 6 Months Ended
Jun. 30, 2026
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value
The Company records all cash flow hedging instruments on the consolidated balance sheets at fair value. The fair values of outstanding derivative instruments designated as cash flow hedging instruments were as follows:
June 30,
December 31,
20262025
Unaudited
Prepaid expenses and other current assets$1,646 $534 
Accrued expenses and other current liabilities$(72)$— 
Schedule of Derivative Instruments, Gain (Loss)
The gains related to cash flow hedging instruments, recorded in the consolidated interim statements of income (loss), for the three and six months ended June 30, 2026 and 2025, were as follows:
Three months ended June 30,Six months ended
June 30,
2026202520262025
Unaudited
Cost of revenues$127 $66 $177 $82 
Research and development1,132 577 1,625 725 
Sales and marketing260 150 369 188 
General and administrative212 108 299 135 
Total gains recognized in the consolidated statements of loss, net$1,731 $901 $2,470 $1,130 
Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss)
The changes in unrealized gains (losses) on the Company’s derivative instruments recorded in accumulated other comprehensive income (loss) were as follows:
Six months ended
June 30,
20262025
Unaudited
Unrealized gains on derivative instruments at the beginning of the period$534 $418 
Changes in fair value of derivative instruments3,447 3,480 
Reclassification of gains recognized in the consolidated interim statements of loss from accumulated other comprehensive income (loss)(2,470)(1,130)
Unrealized gains on derivative instruments at the end of the period (unaudited)$1,511 $2,768